SUTIMCo International

SUTIMCo International was a biotechnology company primarily focused on developing novel antiviral and immunomodulatory treatments for infectious diseases and dermatological conditions. The company's lead candidate, SUT-10, was a proprietary topical formulation designed to treat Herpes Simplex Virus (HSV-1 and HSV-2), demonstrating the ability to significantly reduce lesion healing time and viral shedding in clinical evaluations. SUTIMCo also explored the potential of its technology in preventing the transmission of HIV and treating chronic skin conditions such as psoriasis. Based in Utah, the company aimed to leverage its antimicrobial platform to provide effective, non-invasive therapeutic options, though it appears to have become inactive in recent years.